Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells.

Saved in:
Bibliographic Details
Title: Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells.
Authors: Shu W; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia.; Department of Pharmacy, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangdong Province 511400, China., Wang JZ; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia., Zhu X; Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu Province 214063, China., Wang K; Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu Province 214063, China., Cherepanoff S; SydPath, Department of Anatomical Pathology, St Vincent's Hospital, Darlinghurst, NSW 2010, Australia., Conway RM; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney, NSW 2006, Australia.; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia., Madigan MC; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia.; School of Optometry and Vision Sciences, University of New South Wales, Sydney, NSW 2006, Australia., Lim LA; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney, NSW 2006, Australia.; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia., Zhu H; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang Province 310058, China., Zhu L; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia., Murray M; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia., Zhou F; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia.
Source: Journal of Cancer [J Cancer] 2023 Oct 16; Vol. 14 (18), pp. 3477-3495. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101535920 Publication Model: eCollection Cited Medium: Print ISSN: 1837-9664 (Print) Linking ISSN: 18379664 NLM ISO Abbreviation: J Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1837-9664
DOI:10.7150/jca.88446